+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English
Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Research Report 2021

Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Research Report 2021


  • Publish date: 2016-08-01  | 
  • Pages: 100  | 
  • Tables: 113  | 
  • Hits: 17

  • Publish date: 2016-08-01  | 
  • Pages: 100
  • Tables: 113  | 
  • Hits: 17
Notes:

Sales, means the sales volume of Ventilator Associated Pneumonia (VAP)-Therapeutics

Revenue, means the sales value of Ventilator Associated Pneumonia (VAP)-Therapeutics

This report studies Ventilator Associated Pneumonia (VAP)-Therapeutics in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

    Adenium Biotech

    Aridis Pharmaceuticals

    AstraZeneca

    Merck

    Cardeas Pharma

    Dong-A Socio

    MedImmune

    Meiji Seika Pharma

    Nabriva Therapeutics

    Tetraphase Pharmaceuticals

    Serendex Pharmaceuticals

    Savara Pharmaceuticals

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in these regions, from 2011 to 2021 (forecast), like

    North America

    China

    Europe

    Japan

    India

    Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

    Type I

    Type II

    Type III

Split by application, this report focuses on sales, market share and growth rate of Ventilator Associated Pneumonia (VAP)-Therapeutics in each application, can be divided into

    Application 1

    Application 2

    Application 3

In spite of political and economic instability in the recent past, pharmaceutical and healthcare industry is booming across the globe. Cutting edge technology in medical devices, reformation in biotech & pharmaceuticals, and remarkable growth in the geriatric population are some of the important reasons behind rapidly flourishing healthcare and pharmaceutical industry.

QY Research has offered a comprehensive assessment of the markets in the pharmaceutical & healthcare industry in its recently published research report. This evaluation is done on the basis of historical data, quantitative & qualitative insights and flexible projections about the size of the market. As per the requirement of pharmaceutical and healthcare industry, various techniques are used on an experimental basis to make this report an exclusive one. These techniques are patient-level data, insights on medical technology & devices and comprehensive data on a number of procedures.

Strategies of top players in the pharmaceutical and healthcare industry

QY Research has provided thorough information from vendors along with a complete analysis of the performance of leading players across the globe operating in the pharmaceutical and healthcare industry. One of the important aspects covered in this report is an in-depth evaluation of various markets fall under the purview of the pharmaceutical and healthcare industry and its growth prospects in the years to come. This research report has also included the ideas exchanged between analysts and key players functioning in the industry. 

QY Research has also offered an easily navigable platform which will help clients in assessing their as well as their competitive vendors’ value. This unique feature provided by QY Research would not only help top players in the market in placing their strategies but will also guide them in successfully achieving their targets in the extremely competitive market.

Analysis of market taxonomy   

The markets covered under the purview of the pharmaceutical and healthcare sector are generally segmented as, by product, by application, by end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, bottom-up approach has been used by the experts in pharmaceutical and healthcare sector. While examining different segments of the markets in the pharmaceutical and healthcare industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Regional Analysis

This research report has presented various market segments with an in-depth analysis of key regions. Based on the regions the market is classified into the Middle East and Africa, Eastern & Western Europe, Latin America, the Asia Pacific including Japan and North America. The regional splits of the entire market along with its sub-segments are based on the use of the particular product in the respective regions or countries.

The research analysts in QY Research went the extra mile to provide detail information about the scope of industries in countries such as the United States, Brazil, China, Japan, Malaysia, India and South Korea. There is a huge demand for dietary supplements, veterinary drugs, medicines, human and veterinary vaccines, and blood products across the globe.

North America and Europe region, in particular, have witnessed a large demand for these products because of growing disposable income and thereby improving lifestyle. Due to increasing demands for the pharmaceutical and healthcare products, Gross Domestic Product of the regions and countries has increased and it has led to the market revenue which turns into an increase in the economy of the countries.

Lucid and coherent research reports are the forte of QY Research

For easy and better understanding and organization of the report, experts have classified the report based on the pharmaceutical and healthcare sector in three parts. The first part of the research report consists of an overview of the report which is generally known as the introduction section. This section contains a market viewpoint and in-depth information about the concerned product. 

The second part of the report includes market dynamics such as trends, drivers, restraints and various opportunities. Comprehensive information about pricing analysis is also a part of this section. Regional analysis is provided in the third part of the report.

One of its kind research methodology

The dedicated team of analysts have initially conducted primary research that include various demand-side users such as surgeons, chief opinion leaders, and physicians, while the participants from supply-side providers of various medical devices have offered valuable inputs on patient education, competitive dynamics and pricing, manufacturers and their significant strategies and development of medical devices.

To recognize the viability of the target category of technologies or products and its respective product offerings, segments, the lifespan of various medical devices and to target various healthcare facilities, QY Research has carried out secondary research. Thus each and every piece of information is gradually evaluated over the course of a research project that builds a solid base for secondary as well as primary research.

It is to be noted that these are just initial steps that are being followed by the research team of QY Research. Apart from this, to make this report an exclusive one analysts have done the forecasting based on internal methodology and models developed in QY Research that uses various macro-economic factors such as per capita income and healthcare expenditure.

QY Research, offers detail analysis, research, forecasts and data through the team of market analysts, consultants and industry experts in the process, ensuring the reliability of information through a multi-check audit process. QY Research provides advanced industry-specific models that are used in order to ensure accuracy and completeness of data


READ MORE
Table of Contents

Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Research Report 2021

1 Ventilator Associated Pneumonia (VAP)-Therapeutics Overview

    1.1 Product Overview and Scope of Ventilator Associated Pneumonia (VAP)-Therapeutics

    1.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Segment by Types

        1.2.1 Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type in 2015

        1.2.2 Type I

        1.2.3 Type II

        1.2.4 Type III

    1.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Segment by Applications

        1.3.1 Application 1

        1.3.2 Application 2

        1.3.3 Application 3

    1.4 Ventilator Associated Pneumonia (VAP)-Therapeutics Market by Regions

        1.4.1 North America Status and Prospect (2011-2021)

        1.4.2 China Status and Prospect (2011-2021)

        1.4.3 Europe Status and Prospect (2011-2021)

        1.4.4 Japan Status and Prospect (2011-2021)

        1.4.5 India Status and Prospect (2011-2021)

        1.4.6 Southeast Asia Status and Prospect (2011-2021)

    1.5 Global Market Size (Value and Volume) of Ventilator Associated Pneumonia (VAP)-Therapeutics (2011-2021)

        1.5.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Revenue (2011-2021)

        1.5.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)

        1.5.3 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Competition by Manufacturers

    2.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Share by Manufacturers (2015 and 2016)

    2.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Share by Manufacturers (2015 and 2016)

    2.3 Manufacturers Ventilator Associated Pneumonia (VAP)-Therapeutics Manufacturing Base Distribution and Product Type

    2.4 Competitive Situation and Trends

        2.4.1 Expansions

        2.4.2 New Product Launches

        2.4.3 Acquisitions

        2.4.4 Other Developments

3 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Analysis by Region

    3.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Market Share by Region (2011-2021)

        3.1.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Region (2011-2021)

        3.1.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market Share by Region (2011-2021)

    3.2 North America

        3.2.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.2.2 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

    3.3 Europe

        3.3.1 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.3.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

    3.4 China

        3.4.1 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.4.2 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

    3.5 Japan

        3.5.1 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.5.2 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

    3.6 India

        3.6.1 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.6.2 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

    3.7 Southeast Asia

        3.7.1 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

        3.7.2 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

4 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Analysis by Type

    4.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)

        4.1.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Type (2011-2021)

        4.1.2 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue, Market Share and Growth Rate by Type (2011-2021)

    4.2 Type I Sales, Revenue, Price and Growth (2011-2020)

    4.3 Type II Sales, Revenue, Price and Growth (2011-2020)

    4.4 Type III Sales, Revenue, Price and Growth (2011-2020)

5 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Market Analysis by Application

    5.1 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Market Share by Application (2011-2021)

    5.2 Major Regions Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application in 2015 and 2016

        5.2.1 North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

        5.2.2 Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

        5.2.3 China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

        5.2.4 Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

        5.2.5 India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

        5.2.6 Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application

6 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Manufacturers Analysis

    6.1 Adenium Biotech

        6.1.1 Company Basic Information, Manufacturing Base and Competitors

        6.1.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.1.2.1 Type I

            6.1.2.2 Type II

            6.1.2.3 Type III

        6.1.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Adenium Biotech (2015 and 2016)

    6.2 Aridis Pharmaceuticals

        6.2.1 Company Basic Information, Manufacturing Base and Competitors

        6.2.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.2.2.1 Type I

            6.2.2.2 Type II

            6.2.2.3 Type III

        6.2.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)

    6.3 AstraZeneca

        6.3.1 Company Basic Information, Manufacturing Base and Competitors

        6.3.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.3.2.1 Type I

            6.3.2.2 Type II

            6.3.2.3 Type III

        6.3.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)

    6.4 Merck

        6.4.1 Company Basic Information, Manufacturing Base and Competitors

        6.4.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.4.2.1 Type I

            6.4.2.2 Type II

        6.4.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Merck (2015 and 2016)

    6.5 Cardeas Pharma

        6.5.1 Company Basic Information, Manufacturing Base and Competitors

        6.5.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.5.2.1 Type I

            6.5.2.2 Type II

        6.5.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Cardeas Pharma (2015 and 2016)

    6.6 Dong-A Socio

        6.6.1 Company Basic Information, Manufacturing Base and Competitors

        6.6.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.6.2.1 Type I

            6.6.2.2 Type II

        6.6.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Dong-A Socio (2015 and 2016)

    6.7 MedImmune

        6.7.1 Company Basic Information, Manufacturing Base and Competitors

        6.7.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.7.2.1 Type I

            6.7.2.2 Type II

        6.7.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of MedImmune (2015 and 2016)

    6.8 Meiji Seika Pharma

        6.8.1 Company Basic Information, Manufacturing Base and Competitors

        6.8.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.8.2.1 Type I

            6.8.2.2 Type II

        6.8.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Meiji Seika Pharma (2015 and 2016)

    6.9 Nabriva Therapeutics

        6.9.1 Company Basic Information, Manufacturing Base and Competitors

        6.9.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.9.2.1 Type I

            6.9.2.2 Type II

        6.9.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Nabriva Therapeutics (2015 and 2016)

    6.10 Tetraphase Pharmaceuticals

        6.10.1 Company Basic Information, Manufacturing Base and Competitors

        6.10.2 Ventilator Associated Pneumonia (VAP)-Therapeutics Product Overview

            6.10.2.1 Type I

            6.10.2.2 Type II

        6.10.3 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Tetraphase Pharmaceuticals (2015 and 2016)

    6.11 Serendex Pharmaceuticals

    6.12 Savara Pharmaceuticals

7 Industry Policy Analysis

8 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Ventilator Associated Pneumonia (VAP)-Therapeutics

Figure Global Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type in 2015

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Product Type of by Manufacturers

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2015 and 2016

Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Revenue (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales and Growth Rate (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue and Growth Rate (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers

Figure 2016 Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Manufacturers

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue by Manufacturers (2015 and 2016)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers

Table 2016 Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Manufacturers

Table Manufacturers Ventilator Associated Pneumonia (VAP)-Therapeutics Manufacturing Base Distribution and Product Type

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market by Region (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market by Region (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Region (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market by Region (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Market Share by Region (2011-2021)

Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Price (2011-2021)

Figure Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue and Growth Rate (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Type (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Share by Type (2011-2021)

Figure Sales Market Share of Ventilator Associated Pneumonia (VAP)-Therapeutics by Type (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Type (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue by Type (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Share by Type (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Revenue Growth Rate by Type (2011-2021)

Figure Type I Sales, Revenue and Growth (2011-2021)

Figure Type I Price Trend (2011-2021)

Figure Type II Sales, Revenue and Growth (2011-2021)

Figure Type II Price Trend (2011-2021)

Figure Type III Sales, Revenue and Growth (2011-2021)

Figure Type III Price Trend (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2011-2021)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2015

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Market Share by Application in 2021

Table North America Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table Europe Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table China Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table Japan Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table India Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table Southeast Asia Ventilator Associated Pneumonia (VAP)-Therapeutics Sales by Application (2015 and 2016)

Table Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Application (2011-2021)

Figure Global Ventilator Associated Pneumonia (VAP)-Therapeutics Sales Growth Rate by Application (2011-2021)

Table Adenium Biotech Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Adenium Biotech (2015 and 2016)

Table Aridis Pharmaceuticals Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)

Table AstraZeneca Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of AstraZeneca (2015 and 2016)

Table Merck Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Merck (2015 and 2016)

Table Cardeas Pharma Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Cardeas Pharma (2015 and 2016)

Table Dong-A Socio Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Dong-A Socio (2015 and 2016)

Table MedImmune Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of MedImmune (2015 and 2016)

Table Meiji Seika Pharma Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Meiji Seika Pharma (2015 and 2016)

Table Nabriva Therapeutics Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Nabriva Therapeutics (2015 and 2016)

Table Tetraphase Pharmaceuticals Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Tetraphase Pharmaceuticals (2015 and 2016)

Table Serendex Pharmaceuticals Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Serendex Pharmaceuticals (2015 and 2016)

Table Savara Pharmaceuticals Basic Information List

Table Ventilator Associated Pneumonia (VAP)-Therapeutics Sales, Revenue, Price of Savara Pharmaceuticals (2015 and 2016)

null
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>